These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 32454454)

  • 1. Pulmonary vascular resistance as a potential marker of reactive pulmonary hypertension reduction following sildenafil therapy in patients disqualified from orthotopic heart transplantation.
    Duszańska A; Wasilewski J; Gierlotka M; Zakliczyński M
    Adv Med Sci; 2020 Sep; 65(2):298-303. PubMed ID: 32454454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness and safety of treatment with sildenafil for secondary pulmonary hypertension in heart transplant candidates.
    Zakliczynski M; Maruszewski M; Pyka L; Trybunia D; Nadziakiewicz P; Przybylski R; Zembala M
    Transplant Proc; 2007 Nov; 39(9):2856-8. PubMed ID: 18022001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sildenafil in heart transplant candidates with pulmonary hypertension.
    de Groote P; El Asri C; Fertin M; Goéminne C; Vincentelli A; Robin E; Duva-Pentiah A; Lamblin N
    Arch Cardiovasc Dis; 2015; 108(6-7):375-84. PubMed ID: 25921840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of chronic sildenafil use on pulmonary hemodynamics and clinical outcomes in heart transplantation.
    Pons J; Leblanc MH; Bernier M; Cantin B; Bourgault C; Bergeron S; Proulx G; Morin J; Nalli C; O'Connor K; Chateauvert N; Sénéchal M
    J Heart Lung Transplant; 2012 Dec; 31(12):1281-7. PubMed ID: 23127754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled Iloprost and Oral Sildenafil Combination Therapy: Is it a Chance for Heart Transplant Candidacy?
    Kocabeyoglu SS; Kervan U; Emre Sert D; Temizhan A; Demirkan B; Aygun E; Akdi M; Pac M
    Heart Lung Circ; 2020 Jul; 29(7):1039-1045. PubMed ID: 31818725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Markers of pulmonary hypertension in potential candidates to heart transplantation.
    Wierzbicki K; Przybyłowski P; Sobczyk D; Konstanty J; Kapelak B; Drwiła R; Krochin M; Podolec P; Wójcik S; Marek G; Wróbel K; Piatek J; Rudziński P; Sadowski J
    Przegl Lek; 2006; 63(12):1263-8. PubMed ID: 17642136
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversibility of fixed pulmonary hypertension in left ventricular assist device support recipients.
    Mikus E; Stepanenko A; Krabatsch T; Loforte A; Dandel M; Lehmkuhl HB; Hetzer R; Potapov EV
    Eur J Cardiothorac Surg; 2011 Oct; 40(4):971-7. PubMed ID: 21354812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sildenafil is more selective pulmonary vasodilator than prostaglandin E1 in patients with pulmonary hypertension due to heart failure.
    Al-Hiti H; Melenovský V; Syrovátka P; Kettner J; Málek I; Kautzner J
    Physiol Res; 2011; 60(2):303-8. PubMed ID: 21114369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of sildenafil in acute posttransplant right ventricular dysfunction: successful experience in 13 consecutive patients.
    De Santo LS; Mastroianni C; Romano G; Amarelli C; Marra C; Maiello C; Galdieri N; Della Corte A; Cotrufo M; Caianiello G
    Transplant Proc; 2008; 40(6):2015-8. PubMed ID: 18675118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of milrinone in pre-transplant assessment of patients with congestive heart failure and pulmonary hypertension.
    Pamboukian SV; Carere RG; Webb JG; Cook RC; D'yachkova Y; Abel JG; Ignaszewski AP
    J Heart Lung Transplant; 1999 Apr; 18(4):367-71. PubMed ID: 10226902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Revisiting Pulmonary Hypertension in the Era of Temporary Mechanical Circulatory Support - Literature Review and Case-Based Discussion.
    Sharma S; Ruiz J; Paghdar S; Desai S; Goswami R
    Transplant Proc; 2023 Dec; 55(10):2462-2469. PubMed ID: 37980253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostaglandin E1 testing in heart failure-associated pulmonary hypertension enables transplantation: the PROPHET study.
    von Scheidt W; Costard-Jaeckle A; Stempfle HU; Deng MC; Schwaab B; Haaff B; Naegele H; Mohacsi P; Trautnitz M;
    J Heart Lung Transplant; 2006 Sep; 25(9):1070-6. PubMed ID: 16962468
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modified Model for End-Stage Liver Disease Is an Indicator of the Ineffectiveness of Sildenafil Treatment in Patients With Advanced Heart Failure and Increased Pulmonary Vascular Resistance.
    Szczurek W; Gąsior M; Skrzypek M; Kaczmarski J; Szyguła-Jurkiewicz B
    Transplant Proc; 2020 Oct; 52(8):2440-2446. PubMed ID: 32299711
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pattern of resolution of pulmonary hypertension, long-term allograft right ventricular function, and exercise capacity in high-risk heart transplant recipients listed under oral sildenafil.
    De Santo LS; Buonocore M; Agrusta F; Bancone C; Galdieri N; Romano G; Maiello C; Amarelli C
    Clin Transplant; 2014 Jul; 28(7):837-43. PubMed ID: 24828060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Pharmacological testing of the reversibility of increased pulmonary vascular resistance before heart transplantation with prostaglandin I2 (prostacyclin)].
    Trautnitz M; Pehlivanli S; Behr J; Schwaiblmair M; Uberfuhr P; Meiser B; von Scheidt W
    Z Kardiol; 1999 Feb; 88(2):133-40. PubMed ID: 10209834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of continuous-flow ventricular assist device therapy with intensive medical therapy in fixed pulmonary hypertension secondary to advanced left heart failure.
    Kumarasinghe G; Jain P; Jabbour A; Lai J; Keogh AM; Kotlyar E; Jansz P; Macdonald PS; Hayward CS
    ESC Heart Fail; 2018 Aug; 5(4):695-702. PubMed ID: 29573567
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study.
    Belyavskiy E; Ovchinnikov A; Potekhina A; Ageev F; Edelmann F
    BMC Cardiovasc Disord; 2020 Sep; 20(1):408. PubMed ID: 32912157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of pulmonary hemodynamic parameters in cardiac transplant candidates.
    Sobieszczańska-Małek M; Zieliński T; Piotrowski W; Korewicki J; Of Polkard-Hf OB
    Cardiol J; 2014; 21(5):532-8. PubMed ID: 24526510
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary hemodynamic responses to brain natriuretic peptide and sildenafil in patients with pulmonary arterial hypertension.
    Klinger JR; Thaker S; Houtchens J; Preston IR; Hill NS; Farber HW
    Chest; 2006 Feb; 129(2):417-425. PubMed ID: 16478861
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of pediatric cardiac transplantation candidates with pulmonary hypertension and high pulmonary vascular resistance.
    Yakut K; Varan B; Erdoğan İ; Cindik N; Gökdemir M; Gümüş A; Tokel NK; Sezgin A
    Turk J Pediatr; 2020; 62(3):461-467. PubMed ID: 32558420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.